233 related articles for article (PubMed ID: 20200239)
1. Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.
Liu L; Fisher BE; Dowd KA; Astemborski J; Cox AL; Ray SC
J Virol; 2010 May; 84(10):5067-77. PubMed ID: 20200239
[TBL] [Abstract][Full Text] [Related]
2. Sequence evolution and cross-reactive antibody responses to hypervariable region 1 in acute hepatitis C virus infection.
Hjalmarsson S; Blomberg J; Grillner L; Pipkorn R; Allander T
J Med Virol; 2001 Jun; 64(2):117-24. PubMed ID: 11360243
[TBL] [Abstract][Full Text] [Related]
3. Network Analysis of the Chronic Hepatitis C Virome Defines Hypervariable Region 1 Evolutionary Phenotypes in the Context of Humoral Immune Responses.
Palmer BA; Schmidt-Martin D; Dimitrova Z; Skums P; Crosbie O; Kenny-Walsh E; Fanning LJ
J Virol; 2015 Dec; 90(7):3318-29. PubMed ID: 26719263
[TBL] [Abstract][Full Text] [Related]
4. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.
Farci P; Shimoda A; Coiana A; Diaz G; Peddis G; Melpolder JC; Strazzera A; Chien DY; Munoz SJ; Balestrieri A; Purcell RH; Alter HJ
Science; 2000 Apr; 288(5464):339-44. PubMed ID: 10764648
[TBL] [Abstract][Full Text] [Related]
5. A correlation between the heterogeneity of hypervariable region 1 of E2 glycoprotein of Hepatitis C virus (HCV) and HCV antibody profile: a case study.
Kmieciak D; Biernacka-Lukanty J; Migdalski P; Turek-Plewa J; Wierzbicki A; Juszczyk J; Trzeciak WH
Acta Virol; 2005; 49(2):97-103. PubMed ID: 16047736
[TBL] [Abstract][Full Text] [Related]
6. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
7. Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization.
Anjum S; Wahid A; Afzal MS; Albecka A; Alsaleh K; Ahmad T; Baumert TF; Wychowski C; Qadri I; Penin F; Dubuisson J
J Infect Dis; 2013 Dec; 208(11):1888-97. PubMed ID: 23908491
[TBL] [Abstract][Full Text] [Related]
8. A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution.
Tong Y; Li Q; Li R; Xu Y; Pan Y; Niu J; Zhong J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554700
[TBL] [Abstract][Full Text] [Related]
9. Keyhole Limpet Hemocyanin-Conjugated Peptides from Hepatitis C Virus Glycoproteins Elicit Neutralizing Antibodies in BALB/c Mice.
Deng K; Xu Z; Chen M; Liu X
J Immunol Res; 2021; 2021():3108157. PubMed ID: 33532506
[TBL] [Abstract][Full Text] [Related]
10. Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters.
Allain JP; Dong Y; Vandamme AM; Moulton V; Salemi M
J Virol; 2000 Mar; 74(6):2541-9. PubMed ID: 10684268
[TBL] [Abstract][Full Text] [Related]
11. Envelope-Specific IgG3 and IgG1 Responses Are Associated with Clearance of Acute Hepatitis C Virus Infection.
Walker MR; Eltahla AA; Mina MM; Li H; Lloyd AR; Bull RA
Viruses; 2020 Jan; 12(1):. PubMed ID: 31936235
[TBL] [Abstract][Full Text] [Related]
12. The role of neutralizing antibodies in hepatitis C virus infection.
Edwards VC; Tarr AW; Urbanowicz RA; Ball JK
J Gen Virol; 2012 Jan; 93(Pt 1):1-19. PubMed ID: 22049091
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Hepatitis C Virus (HCV) Envelope Diversification from Acute to Chronic Infection within a Sexually Transmitted HCV Cluster by Using Single-Molecule, Real-Time Sequencing.
Ho CKY; Raghwani J; Koekkoek S; Liang RH; Van der Meer JTM; Van Der Valk M; De Jong M; Pybus OG; Schinkel J; Molenkamp R
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077634
[TBL] [Abstract][Full Text] [Related]
14. Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.
Dowd KA; Netski DM; Wang XH; Cox AL; Ray SC
Gastroenterology; 2009 Jun; 136(7):2377-86. PubMed ID: 19303013
[TBL] [Abstract][Full Text] [Related]
15. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
16. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
[TBL] [Abstract][Full Text] [Related]
17. Evolutionary study of hepatitis C virus envelope genes during primary infection.
Chen S; Wang YM
Chin Med J (Engl); 2007 Dec; 120(24):2174-80. PubMed ID: 18167197
[TBL] [Abstract][Full Text] [Related]
18. In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells.
Sakai A; Takikawa S; Thimme R; Meunier JC; Spangenberg HC; Govindarajan S; Farci P; Emerson SU; Chisari FV; Purcell RH; Bukh J
J Virol; 2007 Jul; 81(13):7208-19. PubMed ID: 17409145
[TBL] [Abstract][Full Text] [Related]
19. Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV Infection.
Swann RE; Cowton VM; Robinson MW; Cole SJ; Barclay ST; Mills PR; Thomson EC; McLauchlan J; Patel AH
J Virol; 2016 May; 90(9):4530-4543. PubMed ID: 26912610
[TBL] [Abstract][Full Text] [Related]
20. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
Zibert A; Schreier E; Roggendorf M
Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
